Europe Synthetic Small Molecule API Market Size, Share & Industry Trends Analysis Report By Manufacturer, By Application (Cardiology, Oncology, CNS & Neurology, Endocrinology, Orthopedic, Gastroenterology, Pulmonology, Nephrology, Ophthalmology), By Count

Europe Synthetic Small Molecule API Market Size, Share & Industry Trends Analysis Report By Manufacturer, By Application (Cardiology, Oncology, CNS & Neurology, Endocrinology, Orthopedic, Gastroenterology, Pulmonology, Nephrology, Ophthalmology), By Country and Growth Forecast, 2022 - 2028

The Europe Synthetic Small Molecule API Market would witness market growth of 5.2% CAGR during the forecast period (2022-2028).

It takes a long time to develop a new drug because there is only a 1:10,000 probability that a novel molecule will be used as a drug. To improve the likelihood of discovering novel lead compounds, a large number of tiny molecules that differ not only in their appendages but also in their chemical skeleton are required.

Organic chemists have developed a wide range of diverse synthetic techniques since the advent of medicinal chemistry as a scientific field in 1930 to the current day to enhance the quality and quantity of tiny molecules that make up a library. It provides an overview of the key methodologies, emphasizing historical context while also covering solid-phase approaches, diversity-oriented synthesis, combinatorial chemistry, and biology-oriented synthesis.

Small molecule medications have traditionally dominated the treatment of human disease. Small molecules can have a wide range of different modes of action and are utilized to treat a wide range of illnesses and ailments. Tiny compounds can act as efficient enzyme inhibitors and allosteric regulators and can target auxiliary variable or intracellular receptors in the cytosol, nucleus, and central nervous system due to their small size and typical physiochemical features. Small molecules continue to be the mainstay of an ever-expanding medicinal toolbox despite apparent limitations and a recent revival.

The growth in demand for molecular quality controls in Europe is primarily driven by the increase in cancer research and associated biomarkers. A study presented at the annual conference of the European Society of Medical Oncology predicts a 21% increase in cancer incidence between 2020 and 2040. The development of the AVENIO Tumor Tissue CGP Kit, which Roche announced would be available in October 2021 and which is intended to assist labs in enhancing internal cancer research, is evidence that efforts to identify biomarkers are also growing. It is expected that Europe will continue to play a significant role in molecular quality controls in the foreseeable future.

The Germany market dominated the Europe Synthetic Small Molecule API Market by Country in 2021; thereby, achieving a market value of $12,468.4 million by 2028. The UK market would witness a CAGR of 4.3% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 6% during (2022 - 2028).

Based on Manufacturer, the market is segmented into In-house and Outsourced. Based on Application, the market is segmented into Cardiology, Oncology, CNS & Neurology, Endocrinology, Orthopedic, Gastroenterology, Pulmonology, Nephrology, Ophthalmology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck & Co., Inc., Viatris, Inc., Cipla Limited, Teva Pharmaceuticals Industries Ltd., Sun Pharmaceuticals Industries Ltd., AbbVie, Inc., Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Aurobindo Pharma Limited and Albermale Corporation

Scope of the Study

Market Segments covered in the Report:

By Manufacturer

  • In-house
  • Outsourced
By Application
  • Cardiology
  • Oncology
  • CNS & Neurology
  • Endocrinology
  • Orthopedic
  • Gastroenterology
  • Pulmonology
  • Nephrology
  • Ophthalmology
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Merck & Co., Inc.
  • Viatris, Inc.
  • Cipla Limited
  • Teva Pharmaceuticals Industries Ltd.
  • Sun Pharmaceuticals Industries Ltd.
  • AbbVie, Inc.
  • Bristol Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Aurobindo Pharma Limited
  • Albermale Corporation
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Synthetic Small Molecule API Market, by Manufacturer
1.4.2 Europe Synthetic Small Molecule API Market, by Application
1.4.3 Europe Synthetic Small Molecule API Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Synthetic Small Molecule API Market by Manufacturer
3.1 Europe In-house Market by Country
3.2 Europe Outsourced Market by Country
Chapter 4. Europe Synthetic Small Molecule API Market by Application
4.1 Europe Cardiology Market by Country
4.2 Europe Oncology Market by Country
4.3 Europe CNS & Neurology Market by Country
4.4 Europe Endocrinology Market by Country
4.5 Europe Orthopedic Market by Country
4.6 Europe Gastroenterology Market by Country
4.7 Europe Pulmonology Market by Country
4.8 Europe Nephrology Market by Country
4.9 Europe Ophthalmology Market by Country
4.1 Europe Others Market by Country
Chapter 5. Europe Synthetic Small Molecule API Market by Country
5.1 Germany Synthetic Small Molecule API Market
5.1.1 Germany Synthetic Small Molecule API Market by Manufacturer
5.1.2 Germany Synthetic Small Molecule API Market by Application
5.2 UK Synthetic Small Molecule API Market
5.2.1 UK Synthetic Small Molecule API Market by Manufacturer
5.2.2 UK Synthetic Small Molecule API Market by Application
5.3 France Synthetic Small Molecule API Market
5.3.1 France Synthetic Small Molecule API Market by Manufacturer
5.3.2 France Synthetic Small Molecule API Market by Application
5.4 Russia Synthetic Small Molecule API Market
5.4.1 Russia Synthetic Small Molecule API Market by Manufacturer
5.4.2 Russia Synthetic Small Molecule API Market by Application
5.5 Spain Synthetic Small Molecule API Market
5.5.1 Spain Synthetic Small Molecule API Market by Manufacturer
5.5.2 Spain Synthetic Small Molecule API Market by Application
5.6 Italy Synthetic Small Molecule API Market
5.6.1 Italy Synthetic Small Molecule API Market by Manufacturer
5.6.2 Italy Synthetic Small Molecule API Market by Application
5.7 Rest of Europe Synthetic Small Molecule API Market
5.7.1 Rest of Europe Synthetic Small Molecule API Market by Manufacturer
5.7.2 Rest of Europe Synthetic Small Molecule API Market by Application
Chapter 6. Company Profiles
6.1 Merck & Co., Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.2 Viatris, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cipla Limited
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expense
6.4 Teva Pharmaceutical Industries Ltd.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 Sun Pharmaceuticals Industries Ltd.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Bristol Myers Squibb Company
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expenses
6.8 Boehringer Ingelheim International Gmbh
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional & Segmental Analysis
6.8.4 Research & Development Expenses
6.9 Aurobindo Pharma Limited
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Albemarle Corporation
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Segmental Analysis
6.10.4 Research & Development Expenses

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings